Akari Therapeutics (AKTX) Net Cash Flow (2014 - 2026)
Akari Therapeutics recorded quarterly Net Cash Flow of -$2.4 million in Q1 2026, down 189.55% quarter-over-quarter from $2.7 million in Q4 2025, and down 14223.53% year-over-year from N/an in Q1 2025.
Akari Therapeutics' Net Cash Flow history runs 13 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 14223.53% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at $185000.0 (down 80.51% YoY), while the FY2025 annual figure was $2.6 million, up 320.22% from the prior year.
- Net Cash Flow came in at -$2.4 million for Q1 2026 at Akari Therapeutics, down from $2.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $7.3 million in Q1 2022 to a low of -$8.6 million in Q2 2022.
- A 5-year average of -$804324.8 and a median of -$892000.0 in 2023 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 8963.33% in 2025 and sank 14223.53% in 2026, its largest moves.
- Akari Therapeutics' Net Cash Flow stood at -$8.6 million in 2022, then soared by 89.6% to -$892000.0 in 2023, then soared by 103.36% to $30000.0 in 2024, then surged by 8963.33% to $2.7 million in 2025, then sank by 189.55% to -$2.4 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$2.4 million, $2.7 million, and -$224000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 57.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.44 Mn |
| Mar 31, 2026 | -2.44 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | -224,000.00 |
| Sep 30, 2025 | -224,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | -1.93 Mn |
| Sep 30, 2024 | -1.93 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | -2.53 Mn |
| Mar 31, 2024 | -2.53 Mn |
| Dec 31, 2023 | -892,000.00 |
| Dec 31, 2023 | -892,000.00 |
| Sep 30, 2023 | -2.45 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | 7.32 Mn |
| Mar 31, 2022 | 7.32 Mn |
| Dec 31, 2021 | 666.33 Bn |
| Dec 31, 2021 | 666.33 Bn |
| Sep 30, 2021 | -666.32 Bn |
| Sep 30, 2021 | -666.32 Bn |
| Jun 30, 2021 | -4.87 Mn |
| Jun 30, 2021 | -4.87 Mn |
| Mar 31, 2021 | -7.42 Mn |
| Mar 31, 2021 | -7.42 Mn |
| Dec 31, 2020 | -6,364.16 Bn |
| Dec 31, 2020 | -6,364.16 Bn |
| Sep 30, 2020 | 6,364.17 Bn |
| Sep 30, 2020 | 6,364.17 Bn |
| Jun 30, 2020 | -2,138.32 Bn |
| Jun 30, 2020 | -2,138.32 Bn |
| Mar 31, 2020 | 2,138.33 Bn |
| Mar 31, 2020 | 2,138.33 Bn |
| Dec 31, 2019 | -688,232.00 |
| Dec 31, 2019 | -688,232.00 |
| Sep 30, 2019 | 3.49 Mn |
| Sep 30, 2019 | 3.49 Mn |
| Jun 30, 2019 | -3.46 Mn |
| Jun 30, 2019 | -3.46 Mn |
| Mar 31, 2019 | 386,687.00 |
| Mar 31, 2019 | 386,687.00 |
| Dec 31, 2018 | -4.23 Mn |
| Dec 31, 2018 | -4.23 Mn |
| Sep 30, 2018 | -4.98 Mn |
| Sep 30, 2018 | -4.98 Mn |
| Jun 30, 2018 | -8.28 Mn |
| Jun 30, 2018 | -8.28 Mn |
| Mar 31, 2018 | -4.40 Mn |
| Mar 31, 2018 | -4.40 Mn |
| Dec 31, 2017 | -8.52 Mn |
| Dec 31, 2017 | -8.52 Mn |
| Sep 30, 2017 | -9.21 Mn |
| Sep 30, 2017 | -9.21 Mn |
| Jun 30, 2017 | 5.29 Mn |
| Jun 30, 2017 | 5.29 Mn |
| Mar 31, 2017 | -9.17 Mn |
| Mar 31, 2017 | -9.17 Mn |
| Dec 31, 2016 | 28.59 Mn |
| Dec 31, 2016 | 28.59 Mn |
| Sep 30, 2016 | -3.98 Mn |
| Sep 30, 2016 | -3.98 Mn |
| Jun 30, 2016 | -51.82 Mn |
| Jun 30, 2016 | -51.82 Mn |
| Mar 31, 2016 | -7.48 Mn |
| Mar 31, 2016 | -7.48 Mn |
| Dec 31, 2015 | -9.85 Mn |
| Dec 31, 2015 | -9.85 Mn |
| Sep 30, 2015 | 78.51 Mn |
| Sep 30, 2015 | 78.51 Mn |
| Jun 30, 2015 | -1.21 Mn |
| Jun 30, 2015 | -1.21 Mn |
| Mar 31, 2015 | -1.99 Mn |
| Mar 31, 2015 | -1.99 Mn |
| Dec 31, 2014 | 3.23 Mn |
| Dec 31, 2014 | 3.23 Mn |
| Sep 30, 2014 | -4.17 Mn |
| Sep 30, 2014 | -4.17 Mn |
| Jun 30, 2014 | -2.47 Mn |
| Jun 30, 2014 | -2.47 Mn |
| Mar 31, 2014 | 6.17 Mn |
| Mar 31, 2014 | 6.17 Mn |